\-\ Texto\\:\\ \ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ medulloblastoma\ \(30\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ neoplasm\\ name\\:\\ medulloblastoma\\ \ \(0\)\
\-\ synonyms\\:\\ pnet\\ \\(primitive\\ neuroectodermal\\ tumor\\)\\,\\ central\\ neuroblastoma\\ \ \(0\)\
\-\ cell\\ of\\ origin\\:\\ \ \(0\)\
\-\ cell\\ of\\ origin\\ is\\ not\\ clear\\.\\ several\\ choices\\ have\\ been\\ offered\\:\\ \ \(0\)\
\-\ 1\\)\\ \\'medulloblasts\\'\\ \ \(5\)\
\-\ 2\\)\\ external\\ granular\\ cells\\ \ \(5\)\
\-\ 3\\)\\ subependymal\\ matrix\\ cells\\ \ \(5\)\
\-\ 4\\)\\ more\\ than\\ one\\ cell\\ of\\ origin\\ \ \(5\)\
\-\ who\\ grade\\(s\\)\\:\\ who\\ 4\\ \ \(0\)\
\-\ genetics\\ and\\ associations\\:\\ \ \(0\)\
\-\ demographics\\ \\(age\\,\\ sex\\,\\ incidence\\)\\:\\ \ \(0\)\
\-\ peak\\ age\\ is\\ 7\\,\\ 70\\%\\ \\<16\\ \\(30\\%\\>15\\)\\,\\ most\\ adults\\ \\<40\\ \ \(0\)\
\-\ 65\\%\\ male\\ \\(\\~2\\:1\\ m\\:f\\)\\ \ \(0\)\
\-\ incidence\\ \\-\\ 0\\.5\\/100k\\ in\\ children\\ \\(\\<15\\ yo\\)\\ \ \(0\)\
\-\ common\\ locations\\:\\ \ \(0\)\
\-\ posterior\\ fossa\\,\\ usually\\ midline\\ \ \(0\)\
\-\ gross\\ appearance\\:\\ \ \(0\)\
\-\ varies\\ from\\ soft\\ to\\ firm\\,\\ some\\ are\\ well\\ defined\\,\\ may\\ be\\ hemorrhagic\\ \ \(0\)\
\-\ radiology\\:\\ \ \(3\)\
\-\ relatively\\ homogeneous\\,\\ may\\ be\\ uniformly\\ hyperdense\\ on\\ non\\-contrast\\ ct\\.\\ mr\\ signal\\ similar\\ to\\ gray\\-matter\\,\\ most\\ not\\ bright\\ on\\ t2w\\ mr\\ \ \(0\)\
\-\ histology\\:\\ \ \(0\)\
\-\ densely\\ cellular\\,\\ hyperchromatic\\ \\"carrot\\-shaped\\"\\ nuclei\\,\\ high\\ nuclear\\ to\\ cytoplasm\\ ratio\\,\\ neuroblastic\\ rosettes\\ \ \(0\)\
\-\ special\\ stains\\:\\ \ \(0\)\
\-\ prognosis\\ and\\ treatment\\:\\ \ \(0\)\
\-\ survival\\ up\\ to\\ 85\\%\\ at\\ five\\ years\\ with\\ combined\\ radiation\\ and\\ chemotherapy\\ \\[magnani\\ c\\,\\ pastore\\ g\\:\\ survival\\ of\\ childhood\\ cancer\\ patients\\ in\\ italy\\,1978\\-1989\\.\\ itacare\\ working\\ group\\.tumori\\ 1997\\ jan\\-feb\\;83\\(1\\)\\:426\\-89\\.\\ \ \(0\)\
\-\ up\\ to\\ 100\\%\\ in\\ pts\\.\\ w\\/o\\ csf\\ spread\\ \\(bourne\\ 1992\\ j\\ neurooncol\\)\\ \ \(0\)\
\-\ \\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\=\\ \ \(5\)\
\-\ see\\ also\\:\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ origin\\:\\ 0\\.20643117825855917\ \(0\)\
\-\ survival\\:\\ 0\\.15602797475777797\ \(0\)\
\-\ incidence\\:\\ 0\\.13762078550570608\ \(0\)\
\-\ cell\\:\\ 0\\.13718206978546946\ \(0\)\
\-\ neuroblastic\\:\\ 0\\.1278358537730743\ \(0\)\
\-\ magnani\\:\\ 0\\.1278358537730743\ \(0\)\
\-\ pastore\\:\\ 0\\.1278358537730743\ \(0\)\
\-\ itacare\\:\\ 0\\.1278358537730743\ \(0\)\
\-\ cells\\:\\ 0\\.12317987820963192\ \(0\)\
\-\ rosettes\\:\\ 0\\.12215398294234438\ \(0\)\
\-\ bourne\\:\\ 0\\.12215398294234438\ \(0\)\
\-\ neurooncol\\:\\ 0\\.12215398294234438\ \(0\)\
\-\ hyperchromatic\\:\\ 0\\.11812263143194102\ \(0\)\
\-\ choices\\:\\ 0\\.11499567226844264\ \(0\)\
\-\ synonyms\\:\\ 0\\.1102806135657872\ \(0\)\
\-\ 15\\:\\ 0\\.10803242112735324\ \(0\)\
\-\ cytoplasm\\:\\ 0\\.10528244992730935\ \(0\)\
\-\ associations\\:\\ 0\\.10394684762843694\ \(0\)\
\-\ mr\\:\\ 0\\.10344510879615788\ \(0\)\
\-\ age\\:\\ 0\\.10036984273452254\ \(0\)\
\-\ to\\:\\ 0\\.099919830560128\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.09961458122084019\ \(0\)\
\-\ demographics\\:\\ 0\\.09960057909657943\ \(0\)\
\-\ densely\\:\\ 0\\.09960057909657943\ \(0\)\
\-\ genetics\\:\\ 0\\.09869618674967448\ \(0\)\
\-\ uniformly\\:\\ 0\\.09869618674967448\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.0978466407260227\ \(0\)\
\-\ name\\:\\ 0\\.09628801168711264\ \(0\)\
\-\ granular\\:\\ 0\\.09628801168711264\ \(0\)\
\-\ sex\\:\\ 0\\.09628801168711264\ \(0\)\
\-\ pts\\:\\ 0\\.09628801168711264\ \(0\)\
\-\ 1992\\:\\ 0\\.09556922758617607\ \(0\)\
\-\ offered\\:\\ 0\\.09488552039392399\ \(0\)\
\-\ stains\\:\\ 0\\.09488552039392399\ \(0\)\
\-\ cellular\\:\\ 0\\.09244226842267769\ \(0\)\
\-\ varies\\:\\ 0\\.09189266003080934\ \(0\)\
\-\ primitive\\:\\ 0\\.09136379659861799\ \(0\)\
\-\ special\\:\\ 0\\.09136379659861799\ \(0\)\
\-\ who\\:\\ 0\\.09043402991614596\ \(0\)\
\-\ working\\:\\ 0\\.08988735675544615\ \(0\)\
\-\ nuclei\\:\\ 0\\.08813341838488942\ \(0\)\
\-\ pnet\\:\\ 0\\.08585600524504282\ \(0\)\
\-\ subependymal\\:\\ 0\\.08517229805279074\ \(0\)\
\-\ histology\\:\\ 0\\.0848425600699311\ \(0\)\
\-\ locations\\:\\ 0\\.08359611958428254\ \(0\)\
\-\ most\\:\\ 0\\.08320274260368166\ \(0\)\
\-\ peak\\:\\ 0\\.08191251118671006\ \(0\)\
\-\ 83\\:\\ 0\\.08114094654238738\ \(0\)\
\-\ childhood\\:\\ 0\\.08089291851524943\ \(0\)\
\-\ t2w\\:\\ 0\\.08064920423840032\ \(0\)\
\-\ may\\:\\ 0\\.08045312720502\ \(0\)\
\-\ matrix\\:\\ 0\\.08040965622223378\ \(0\)\
\-\ ratio\\:\\ 0\\.08017413441431288\ \(0\)\
\-\ combined\\:\\ 0\\.07926974206740793\ \(0\)\
\-\ up\\:\\ 0\\.0790831414699562\ \(0\)\
\-\ 1997\\:\\ 0\\.07905247852617767\ \(0\)\
\-\ nuclear\\:\\ 0\\.07562690068404307\ \(0\)\
\-\ adults\\:\\ 0\\.07464883747732114\ \(0\)\
\-\ 85\\:\\ 0\\.07373460784134768\ \(0\)\
\-\ hyperdense\\:\\ 0\\.07358787123667802\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.07344265524594318\ \(0\)\
\-\ bright\\:\\ 0\\.07287638758795274\ \(0\)\
\-\ firm\\:\\ 0\\.07246621534854278\ \(0\)\
\-\ five\\:\\ 0\\.07219928884557678\ \(0\)\
\-\ spread\\:\\ 0\\.07180819692187632\ \(0\)\
\-\ gross\\:\\ 0\\.07093598189726703\ \(0\)\
\-\ homogeneous\\:\\ 0\\.07057817817760231\ \(0\)\
\-\ prognosis\\:\\ 0\\.0703446191426663\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.06933925618504438\ \(0\)\
\-\ 65\\:\\ 0\\.06840121864141832\ \(0\)\
\-\ 70\\:\\ 0\\.0659983506108088\ \(0\)\
\-\ 100\\:\\ 0\\.06558001453912447\ \(0\)\
\-\ children\\:\\ 0\\.06549782534338623\ \(0\)\
\-\ relatively\\:\\ 0\\.06509395826390385\ \(0\)\
\-\ be\\:\\ 0\\.06485407866105022\ \(0\)\
\-\ external\\:\\ 0\\.06462419748238896\ \(0\)\
\-\ radiology\\:\\ 0\\.06402138550021441\ \(0\)\
\-\ csf\\:\\ 0\\.06316316524681947\ \(0\)\
\-\ not\\:\\ 0\\.06311405151848563\ \(0\)\
\-\ fossa\\:\\ 0\\.06275299300740951\ \(0\)\
\-\ of\\:\\ 0\\.06257287108579945\ \(0\)\
\-\ 16\\:\\ 0\\.06228915622416615\ \(0\)\
\-\ similar\\:\\ 0\\.060923958945544726\ \(0\)\
\-\ midline\\:\\ 0\\.060119701172656\ \(0\)\
\-\ in\\:\\ 0\\.05965681521663129\ \(0\)\
\-\ 40\\:\\ 0\\.05878917520700433\ \(0\)\
\-\ clear\\:\\ 0\\.05795158075567837\ \(0\)\
\-\ grade\\:\\ 0\\.05748129441608955\ \(0\)\
\-\ defined\\:\\ 0\\.05702627984176577\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.05676019809376296\ \(0\)\
\-\ neoplasm\\:\\ 0\\.054568708576691945\ \(0\)\
\-\ 30\\:\\ 0\\.05453118989911878\ \(0\)\
\-\ central\\:\\ 0\\.05338074168997994\ \(0\)\
\-\ cancer\\:\\ 0\\.053243356102269636\ \(0\)\
\-\ radiation\\:\\ 0\\.05297256086020871\ \(0\)\
\-\ several\\:\\ 0\\.05244618094024409\ \(0\)\
\-\ usually\\:\\ 0\\.0503229837421878\ \(0\)\
\-\ some\\:\\ 0\\.050295262234230156\ \(0\)\
\-\ yo\\:\\ 0\\.049939785943643275\ \(0\)\
\-\ see\\:\\ 0\\.04972543044161286\ \(0\)\
\-\ and\\:\\ 0\\.04955369256440095\ \(0\)\
\-\ years\\:\\ 0\\.04900000028046039\ \(0\)\
\-\ on\\:\\ 0\\.048284385661125515\ \(0\)\
\-\ appearance\\:\\ 0\\.04819061316323708\ \(0\)\
\-\ been\\:\\ 0\\.04657190592854225\ \(0\)\
\-\ one\\:\\ 0\\.04576739438725768\ \(0\)\
\-\ high\\:\\ 0\\.04543066482729218\ \(0\)\
\-\ common\\:\\ 0\\.04533314726115176\ \(0\)\
\-\ than\\:\\ 0\\.045313724918884406\ \(0\)\
\-\ signal\\:\\ 0\\.045313724918884406\ \(0\)\
\-\ patients\\:\\ 0\\.044968648770057046\ \(0\)\
\-\ more\\:\\ 0\\.04389368419609765\ \(0\)\
\-\ is\\:\\ 0\\.04378230313430691\ \(0\)\
\-\ soft\\:\\ 0\\.04255648758381518\ \(0\)\
\-\ tumor\\:\\ 0\\.04181142346584574\ \(0\)\
\-\ posterior\\:\\ 0\\.04133584975949427\ \(0\)\
\-\ have\\:\\ 0\\.03993266265867856\ \(0\)\
\-\ well\\:\\ 0\\.03870564373505617\ \(0\)\
\-\ treatment\\:\\ 0\\.03807799295576808\ \(0\)\
\-\ also\\:\\ 0\\.037599835159499224\ \(0\)\
\-\ male\\:\\ 0\\.03559080149207287\ \(0\)\
\-\ from\\:\\ 0\\.031747385875786106\ \(0\)\
\-\ ct\\:\\ 0\\.030432573212407374\ \(0\)\
\-\ are\\:\\ 0\\.03033226342329329\ \(0\)\
\-\ at\\:\\ 0\\.03019302519624084\ \(0\)\
\-\ with\\:\\ 0\\.015652564590340732\ \(0\)\
